Stock Market Today, May 28: Tech Stocks Rise as Snowflake Surges After $6 Billion Amazon Deal and Strong Earnings

Markets were broadly firmer, with the S&P 500 up 0.49%, the Nasdaq up 0.65%, and the Dow essentially flat at -0.01%. Snowflake was the standout, surging 38% after blowout Q1 earnings, 33% sales growth, and a $6 billion deal with Amazon; Microsoft also rose on in-house AI model plans, while Eli Lilly gained after CVS restored Zepbound coverage. Consumer stocks were strong too, with Dollar Tree up 19%, Best Buy 18%, and Hormel 13%, though Synopsys fell 9% despite beating earnings and raising guidance.

Analysis

The clearest read-through is that enterprise AI spend is becoming less speculative and more budgetable. Snowflake’s move matters less as a one-day stock reaction than as evidence that large customers are willing to sign multibillion-dollar infrastructure commitments when the platform is tied to AI workflows and data gravity; that supports higher cloud/data-platform multiples across the cohort, especially vendors with usage-based monetization and embedded AI features. The second-order loser is not just legacy analytics software, but any vendor whose roadmap depends on “wait and see” enterprise IT cycles now that buyers are demonstrating willingness to pre-commit spend for AI capacity.

The consumer tape is more nuanced than a simple “healthy household” signal. Strong prints from discount and discretionary names suggest trade-down behavior is still alive even as spending holds up, which is typically a good setup for value chains with pricing power and inventory discipline. That favors operators that can flex mix and promotions quickly; it is less constructive for mid-tier retailers and brands that need full-price sell-through, because the market will likely reward firms showing traffic resilience while punishing anyone with margin fragility or stale inventory turns.

Synopsys’ post-earnings weakness looks like a positioning event as much as a fundamentals issue. In the short run, the market may be using any semiconductor-adjacent winner to fund crowded AI exposure, which can compress multiple expansion even on decent guidance. Over a 3-6 month horizon, the key risk is that investors extrapolate current AI capex into design-tool demand too aggressively; if hyperscaler spending normalizes or product cycles elongate, the selloff could persist despite operational strength.

The contrarian angle is that the market may be underestimating how broadening AI benefits are beyond the obvious winners. Amazon’s deal with Snowflake is strategically useful because it reduces friction between cloud infrastructure and enterprise data layers, but it can also intensify competitive pressure on other clouds to match integrated offerings, potentially lifting industry capex but narrowing differentiation. If that dynamic continues, the highest-quality compounders may be the picks-and-shovels providers with recurring revenue and platform lock-in, not the most visible AI application names.

Key Decisions for Investors

• Go long SNOW on a 1-3 month horizon via call spreads or a starter equity position; risk/reward favors continuation if large-deal conversion is proving durable, but size modestly because post-earnings gaps often retrace 20-30% of the move.
• Pair long SNOW / short SNPS for a 4-8 week relative-value trade; both are software-infrastructure names, but SNOW has a clearer AI monetization catalyst while SNPS is more exposed to any pause in semiconductor design spend.
• Buy AMZN on pullbacks over the next 2-6 weeks as the Snowflake tie-up reinforces AWS as an enterprise AI distribution layer; use a smaller-than-normal sizing because the market may already be pricing some strategic benefit.
• Favor DLTR and BBY over WMT/TGT in the next 1-2 quarters on a relative basis if consumer trade-down remains intact; the opportunity is in mix improvement and traffic gains, but monitor gross margin pressure closely.
• Avoid chasing CVS after the healthcare headline; the catalyst is policy- and reimbursement-driven, so upside is likely more gradual. If owning, treat it as a 6-12 month income/re-rating holding rather than a near-term momentum trade.